相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Design, synthesis, and evaluation of novel pyridone derivatives as potent BRD4 inhibitors for the potential treatment of prostate cancer
Wenhua Jiang et al.
BIOORGANIC CHEMISTRY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
The BET family in immunity and disease
Nian Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Thermal shift assay: Strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclase
Christin Elgert et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Targeting BET bromodomain proteins in cancer: The example of lymphomas
Filippo Spriano et al.
PHARMACOLOGY & THERAPEUTICS (2020)
(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
Mengqiu Song et al.
CANCERS (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
Pharmacokinetics of a ternary conjugate based pH-responsive 10-HCPT prodrug nano-micelle delivery system
Yang Liu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies
Daniel Martinez Molina et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Clinical progress and pharmacology of small molecule bromodomain inhibitors
Natalie H. Theodoulou et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
Jae-Seok Roe et al.
MOLECULAR CELL (2015)
Protein-ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI)
Morten K. Groftehauge et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Pharmacological Inhibition of Bromodomain-Containing Proteins in Inflammation
Uwe Schaefer
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Cooperative binding of two acetylation marks on a histone tail by a single bromodomain
Jeanne Moriniere et al.
NATURE (2009)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)